Last update 13 May 2025

MUC1 antigen/SB AS-2(NCI)

Overview

Basic Info

Drug Type
Therapeutic vaccine
Synonyms-
Target-
Action
stimulants
Mechanism
Immunostimulants
Therapeutic Areas
NeoplasmsDigestive System DisordersEndocrinology and Metabolic Disease
Active Indication-
Inactive Indication
Locally Advanced Pancreatic AdenocarcinomaPancreatic carcinoma non-resectable
Originator Organization
National Cancer InstituteNational Cancer Institute
Active Organization-
Inactive Organization
University of PittsburghUniversity of Pittsburgh
License Organization-
Drug Highest PhasePendingPhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with MUC1 antigen/SB AS-2(NCI)
NCT00008099
/ CompletedPhase 1IIT
Phase I Dose Escalation Trial of a 100 aa Synthetic Mucin Peptide Admixed With SB-AS2 as Adjuvant in Locally Advanced and Resected Pancreatic Cancer
100 Clinical Results associated with MUC1 antigen/SB AS-2(NCI)
Login to view more data
100 Translational Medicine associated with MUC1 antigen/SB AS-2(NCI)
Login to view more data
100 Patents (Medical) associated with MUC1 antigen/SB AS-2(NCI)
Login to view more data
100 Deals associated with MUC1 antigen/SB AS-2(NCI)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Locally Advanced Pancreatic AdenocarcinomaPhase 1
United States
University of PittsburghUniversity of Pittsburgh
01 May 1998
Pancreatic carcinoma non-resectablePhase 1
United States
University of PittsburghUniversity of Pittsburgh
01 May 1998
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free